NiKem is Accepted by the FMR

Contract Research Organizations, for the most part, are inherently global. NiKem Research Srl, is not an exception. As announced here, they recently received good news from the French Ministry of Research (FMR). The FMR has approved them to reach the status of “Crédit d’Impôt Recherche”. This allows the CRO, NiKem, to conduct Research and Development activities for private French companies. Guesseppe Giardina, CEO of NiKem, released this statement:

"The approval as a C.I.R. certified company by the French Ministry of Research is an important step forward for NiKem. We believe that our already significant business volume with French pharmaceutical and, most importantly, biotech companies will grow: in fact, our high quality standards are now combined with competitive prices and tax credit options. Thus, we expect to at least double our revenues in France in the next three years."